301393 昊帆生物
按盤價 
51.980 +1.290 (+2.545%)
51.980 +1.290 (+2.545%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.298 | 5.984 | 7.347 | 30.268 | 35.176 |
| 總資產報酬率 ROA (%) | 4.051 | 5.782 | 6.857 | 24.292 | 28.250 |
| 投入資產回報率 ROIC (%) | 4.240 | 5.947 | 7.241 | 28.561 | 33.292 | 邊際利潤分析 |
| 銷售毛利率 (%) | 38.746 | 40.282 | 38.553 | 43.258 | 46.443 |
| 營業利潤率 (%) | 26.363 | 34.499 | 28.952 | 33.353 | 34.958 |
| 息稅前利潤/營業總收入 (%) | 24.300 | 26.960 | 21.907 | 32.397 | 35.409 |
| 淨利潤/營業總收入 (%) | 22.829 | 29.666 | 25.457 | 28.912 | 30.154 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 85.989 | 85.063 | 97.992 | 98.457 | 98.713 |
| 價值變動淨收益/利潤總額(%) | 17.943 | 10.726 | 1.541 | 0.265 | 0.915 |
| 營業外收支淨額/利潤總額(%) | -0.679 | -0.812 | -0.068 | -0.191 | -0.075 | 償債能力分析 |
| 流動比率 (X) | 10.094 | 27.321 | 29.832 | 3.226 | 3.421 |
| 速動比率 (X) | 9.236 | 25.681 | 28.085 | 2.188 | 2.491 |
| 資產負債率 (%) | 7.858 | 3.462 | 3.283 | 19.627 | 19.894 |
| 帶息債務/全部投入資本 (%) | 1.218 | 0.237 | 0.158 | 3.600 | 4.187 |
| 股東權益/帶息債務 (%) | 8,050.205 | 41,891.257 | 62,960.856 | 2,631.580 | 2,241.845 |
| 股東權益/負債合計 (%) | 1,172.580 | 2,788.264 | 2,946.103 | 409.499 | 402.652 |
| 利息保障倍數 (X) | -12.889 | -3.713 | -3.119 | -36.296 | 74.123 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.335 | 61.174 | 51.630 | 47.038 | 50.348 |
| 存貨周轉天數 (天) | 138.264 | 154.552 | 172.124 | 136.362 | 119.462 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
